A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice

Background: Pancreatic cancer (PC) is the fourth-most-deadly cancer in the United States with a 5-year survival rate of only 8%. Unfortunately, only 10–20% of PC patients are candidates for surgery, with the vast majority of patients with locally-advanced disease undergoing chemotherapy and/or radia...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmood, Javed, Alexander, Allen A., Samanta, Santanu, Kamlapurkar, Shriya, Singh, Prerna, Saeed, Ali, Carrier, France, Cao, Xuefang, Shukla, Hem D, Vujaskovic, Zeljko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226594/
https://www.ncbi.nlm.nih.gov/pubmed/32326142
http://dx.doi.org/10.3390/cancers12041015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226594/
https://www.ncbi.nlm.nih.gov/pubmed/32326142
http://dx.doi.org/10.3390/cancers12041015

Ejemplares similares